Stock listing

TSX:TRIL Trillium Therapeutics Inc Stock

Follow Trillium Therapeutics Inc into a list and get an email when it puts out news.

Delisted TSX:TRIL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
TSX:TRIL
Asset type
Stock
Exchange
TSX
Currency
CAD

Latest news

All Trillium Therapeutics Inc news

Trillium Therapeutics Inc on 6ix

News releases
15 in all · newest Sep 14, 2017 · oldest 2006
Decks
1 deck · latest Apr 28, 2021

Where Trillium Therapeutics Inc is listed

ListingExchangeCountryCurrency
TSX:TRIL · This page · DelistedTSXCanadaCAD
NASDAQ:TRIL · DelistedNASDAQUnited StatesUSD

Decks

DeckKindSlidesDate
Investor Day (April 2021)Investor day112 slidesApr 28, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paolo Pucci
Other companies: Replimune Group, Inc. (Director · Since at least Apr 1, 2020); West Pharmaceutical Services, Inc. (Director · Since at least Sep 12, 2016); Lumos Pharma Inc (Director · Nov 12, 2015 – May 23, 2018 · Past); Dyax Corp (Director · Nov 1, 2011 – Jan 13, 2016 · Past); ArQule Inc (Chief Executive Officer, Director · Jun 9, 2008 – Jan 16, 2020 · Past)
Director · Jan 1, 2021 – Nov 17, 2021 · Past
Luke Beshar
Other companies: Protara Therapeutics, Inc. (Chairman · Since at least Jan 9, 2020); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 7, 2023 · Past); Regenxbio Inc. (Director · Sep 16, 2015 – Jun 4, 2021 · Past)
Director · Jan 1, 2021 – Nov 17, 2021 · Past
Helen Tayton-Martin
Other companies: Evaxion A/S (Chief Executive Officer · Since at least Mar 18, 2026); Adaptimmune Therapeutics PLC (Chief Business & Strgy Officer · Jan 1, 2016 – Jan 15, 2024 · Past)
Director · Jan 1, 2021 – Nov 17, 2021 · Past
James Parsons
Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); DiaMedica Therapeutics Inc. (Chairman of the Board · Since at least Dec 6, 2018)
Chief Financial Officer · Jan 1, 2021 – Nov 17, 2021 · Past
Jan Skvarka
Other companies: Monte Rosa Therapeutics, Inc. (Executive Chairman, DEM Biopharma · Since at least Mar 23, 2023); Zentalis Pharmaceuticals, Inc. (Director · Since at least Sep 9, 2022)
President and CEO, Director · Jan 1, 2021 – Nov 17, 2021 · Past
Benjamin Looker
Other companies: Esperion Therapeutics, Inc. (Chief Legal Officer · Since at least Jan 1, 2022)
General Counsel · Apr 26, 2021 – Nov 17, 2021 · Past
Rosemary Harrison
Other companies: Tcr2 Therapeutics Inc (Chief Business & Strategy · Jan 10, 2022 – Jun 1, 2023 · Past)
See Remarks · Jan 1, 2021 – Nov 17, 2021 · Past
Robert UgerChief Scientific Officer · Jan 1, 2021 – Nov 17, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Trillium Therapeutics Inc.